StockComparison Logo
vs

SNSE vs HIND

Comparison between Sensei Biotherapeutics Inc (SNSE, Company) and ReShape Lifesciences Inc (HIND, Company).

Both SNSE and HIND are from the Healthcare sector.

5-Year PerformanceSNSE has outperformed HIND, delivering a return of -43.6% compared to -93.4%

SNSE vs HIND - Performance Comparison

Key Characteristics

Financial metrics and valuation ratios

Market Cap
Winner
SNSE
$15M
HIND
$15M
Max Drawdown
Winner
SNSE
98.73%
HIND
100.00%
Sharpe Ratio
Winner
SNSE
0.98
HIND
-0.84
5Y Beta
SNSE
1.16
Winner
HIND
0.00
Industry
SNSE
Biotechnology
HIND
Biotechnology
P/E Ratio
SNSE
-0.08
Winner
HIND
-0.54
PEG Ratio
SNSE
-0.00
HIND
N/A
Debt to Equity
SNSE
0.00%
HIND
0.00%
Free Cash Flow Yield
SNSE
N/A
HIND
-20.08%
P/S Ratio
SNSE
N/A
HIND
99.95
P/B Ratio
Winner
SNSE
1.26
HIND
2.26

SNSE vs HIND - Historical Returns

Returns include dividend reinvestment.

1M
SNSE
-28.88%
Winner
HIND
+15.34%
3M
SNSE
-51.40%
Winner
HIND
+2.83%
6M
Winner
SNSE
+79.83%
HIND
-44.95%
1Y
Winner
SNSE
+122.85%
HIND
-79.59%
5Y(CAGR)
Winner
SNSE
-43.59%
HIND
-93.38%
10Y(CAGR)
SNSE
N/A
HIND
-82.34%
Max(CAGR)
Winner
SNSE
-45.55%
HIND
-82.34%

SNSE vs HIND - Annual Returns (2016 - 2026)

Returns include dividend reinvestment.

YearSNSEHIND
2026+50.65%-38.59%
2025+3.59%-99.25%
2024-37.68%-71.18%
2023-51.94%-98.41%
2022-75.45%-92.75%
2021-69.31%+13.10%
2020N/A-20.21%
2019N/A-91.74%
2018N/A-71.05%
2017N/A-27.84%
2016N/A-41.00%

SNSE vs HIND Drawdown Comparison

The maximum drawdown for SNSE was -98.73%, occurring on Apr 4, 2025. This drawdown has not yet recovered.

The maximum drawdown for HIND was -100.00%, occurring on May 15, 2026. This drawdown has not yet recovered.

The current SNSE drawdown is -96.81%. The current HIND drawdown is -100.00%.

RankSNSEHIND
#1-98.73%
Feb 8, 2021 - Apr 4, 2025
-100.00%
Oct 6, 2016 - May 15, 2026

Correlation

Correlation between SNSE and HIND is 0.91 which considered as a very strong positive correlation - the stocks move almost identically together.

0.91
-101

Select Stocks to Compare